$金斯瑞生物科技(01548)$ CPASS 潜力好大，有药企预测市场是800亿美金。

Todos 看到了 cPass 的巨大市场机遇，它将开始蚕食 COVID-19 PCR 测试市场，该市场在 2020 年迅速发展为全球 800 亿美元的市场。

Todos sees a large market opportunity developing for cPass that will begin to encroach on the COVID-19 PCR testing market that rapidly developed into an $80 billion market worldwide in 2020.

Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement with Fosun Pharma$复星医药(02196)$$复星医药(SH600196)$
July 19, 2021 08:31 ET | Source: Todos Medical Ltd.



...


 

网页链接